Published in BMC Med on September 24, 2004
Radiation therapy in the postoperative management of esophageal cancer. J Gastrointest Oncol (2010) 1.48
Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer (2006) 1.17
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg (2008) 1.15
High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol (2007) 1.15
Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol (2009) 1.13
Multimodality management of esophageal cancer. Indian J Surg Oncol (2013) 1.03
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma? World J Surg Oncol (2012) 0.99
Volumetric modulated arc therapy planning for distal oesophageal malignancies. Br J Radiol (2011) 0.97
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline. BMC Cancer (2004) 0.96
Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol (2011) 0.94
Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis. Dig Dis Sci (2012) 0.94
Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy. World J Gastroenterol (2005) 0.93
Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma. Int J Clin Oncol (2008) 0.90
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation. Cancer (2011) 0.90
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer (2014) 0.89
Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer (2006) 0.88
Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses. World J Surg (2009) 0.87
Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery : early results and toxicity. Strahlenther Onkol (2011) 0.87
Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma. J Korean Med Sci (2014) 0.86
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma. Br J Cancer (2009) 0.85
Multimodality management of esophageal cancer. Indian J Surg (2014) 0.83
Adjuvant Therapy for Positive Nodes After Induction Therapy and Resection of Esophageal Cancer. Ann Thorac Surg (2015) 0.82
Radical Esophagectomy After Neoadjuvant Chemoradiation: Single Institutional Experience from Tertiary Cancer Centre in India. Indian J Surg Oncol (2015) 0.80
Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer. World J Gastrointest Pathophysiol (2014) 0.80
The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2015) 0.78
Trimodal therapy in squamous cell carcinoma of the esophagus. Eur J Med Res (2011) 0.76
Undervalued criteria in the evaluation of multimodal trials for upper GI cancers. Cancer Invest (2014) 0.75
An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer. J Hum Genet (2014) 0.75
In pursuit of progress: multimodality strategies will form the cornerstone of cure for esophageal cancer. Gastrointest Cancer Res (2009) 0.75
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med (1996) 9.85
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet (2002) 8.46
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol (2001) 6.07
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med (1997) 4.94
Surgical therapy of oesophageal carcinoma. Br J Surg (1990) 3.94
Transhiatal esophagectomy: clinical experience and refinements. Ann Surg (1999) 3.24
A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg (2003) 3.10
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg (2003) 2.88
Oesophogeal squamous cell carcinoms: II. A critical view of radiotherapy. Br J Surg (1980) 2.67
Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg (1993) 2.18
A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer (1994) 2.17
Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg (1997) 2.09
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol (1998) 1.80
Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery . J Clin Oncol (1992) 1.70
A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg (1997) 1.68
Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet (1991) 1.64
A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology (1994) 1.55
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg (1988) 1.54
Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg (1997) 1.53
Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery (1993) 1.47
A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg (2002) 1.40
The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg (1987) 1.40
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.36
Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer (1982) 1.35
Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg (1995) 1.26
Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet (1981) 1.24
Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol (1992) 1.20
Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg (1992) 1.19
Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol (1990) 1.19
Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys (1989) 1.09
Carcinoma of the esophagus. An autopsy study of 231 cases. Pathology (1986) 1.05
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol (1990) 1.03
Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg (1992) 1.00
Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest (1988) 0.99
A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group. Chest (1993) 0.98
Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol (1994) 0.97
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline. BMC Cancer (2004) 0.96
Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies. Ann Oncol (1996) 0.94
Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys (2003) 0.90
Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan. Am J Clin Oncol (1995) 0.89
Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol (1994) 0.88
Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival. Dis Esophagus (2002) 0.88
The quality of swallowing for patients with operable esophageal carcinoma: a randomized trial comparing surgery with radiotherapy. Cancer (1999) 0.87
Treatment of locoregional esophageal cancer. Semin Oncol (1992) 0.84
Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol (1995) 0.83
Three-field lymphadenectomy for esophageal cancer. Chest Surg Clin N Am (2000) 0.81
Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer. Radiother Oncol (1984) 0.79
Preoperative radiotherapy for esophageal carcinoma. Oeosphageal Cancer Collaborative Group. Cochrane Database Syst Rev (2000) 0.78
Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol (2002) 2.25
Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol (2004) 1.86
Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base. Can Urol Assoc J (2010) 1.55
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can J Surg (2002) 1.47
Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol (2012) 1.14
Mechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1). J Biol Chem (2010) 1.12
The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review. Can J Gastroenterol (2005) 1.03
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline. BMC Cancer (2004) 0.96
The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline. BMC Med (2003) 0.91
Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys (2003) 0.90
Adjuvant chemotherapy for adults with malignant glioma: a systematic review. Can J Neurol Sci (2007) 0.88
The treatment of locally advanced pancreatic cancer: a practice guideline. Can J Gastroenterol (2003) 0.85
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med (2017) 0.75
Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med (2016) 0.75